Barclays Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight

January 10, 2014 7:29 AM EST Send to a Friend
Get Alerts BMY Hot Sheet
Price: $50.65 +0.22%

Rating Summary:
    10 Buy, 7 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade BMY Now!
Join SI Premium – FREE
Barclays upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Equalweight to Overweight with a price target of $65.00 (from $52.00).

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $55.03 yesterday.




You May Also Be Interested In


Related Categories

Analyst PT Change, Upgrades

Related Entities

Barclays

Add Your Comment